Giraffe Bio

📍 Buenos Aires City, Argentina🗓 Founded 2024👥 10 employees💰 Last funded Jan 2025
Biotechnology Research🌐 giraffe-bio.com
Website LinkedIn
Giraffe Bio develops programmable biomolecular reagents for mineral processing. We design molecules that act directly at the mineral surface, enabling more selective and efficient metal recovery across complex orebodies and brines. As resource quality declines and variability increases, conventional chemistry struggles to adapt. Operators are forced to balance recovery, grade, and cost under tighter constraints. Our reagents are engineered for specific mineral systems and deployed as drop-in solutions within existing processes, allowing performance improvements without changes to infrastructure or operating philosophy. At the core of the company is a discovery platform that integrates biology, engineering, and data to design, test, and refine molecular solutions. Each program builds on prior learning, enabling faster iteration and increasingly precise targeting over time. We work with mining partners to develop and implement these solutions across a range of applications. Giraffe Bio is building a new layer of performance in mining, where control at the molecular level enables more efficient and adaptable resource extraction.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Giraffe Bio?
Giraffe Bio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Giraffe Bio last raise funding?
The most recent investment in Giraffe Bio recorded on gritt.io was in January 2025.
When was Giraffe Bio founded?
Giraffe Bio was founded in 2024.
What industry is Giraffe Bio in?
Giraffe Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Giraffe Bio based?
Giraffe Bio is headquartered in Buenos Aires City, Argentina.